RIL
EDIT icon

Rothschild Investment LLC’s Editas Medicine EDIT Stock Holding History

Rothschild Investment LLC’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96K Buy
914
+324
+55% +$947 ﹤0.01% 2583
2026
Q1 		$1.46K Buy
590
+440
+293% +$931 ﹤0.01% 2704
2025
Q4 		$308 Hold
150
– – ﹤0.01% 3039
2025
Q3 		$521 Sell
150
-150
-50% -$419 ﹤0.01% 2815
2025
Q2 		$660 Buy
300
+150
+100% +$245 ﹤0.01% 2645
2025
Q1 		$174 Buy
150
+20
+15% +$29 ﹤0.01% 2881
2024
Q4 		$165 Buy
130
+105
+420% +$268 ﹤0.01% 2828
2024
Q3 		$85 Hold
25
– – ﹤0.01% 2861
2024
Q2 		$117 Buy
25
+10
+67% +$56 ﹤0.01% 2688
2024
Q1 		$111 Buy
+15
New +$125 ﹤0.01% 2159
2020
Q4 		– Sell
-8,050
Closed -$226K – 460
2020
Q3 		$226K Sell
8,050
-300
-4% -$9.77K 0.02% 377
2020
Q2 		$247K Buy
+8,350
New +$218K 0.03% 350
2020
Q1 		– Sell
-9,150
Closed -$271K – 438
2019
Q4 		$271K Sell
9,150
-200
-2% -$5K 0.03% 378
2019
Q3 		$213K Hold
9,350
– – 0.02% 354
2019
Q2 		$231K Hold
9,350
– – 0.03% 341
2019
Q1 		$229K Hold
9,350
– – 0.03% 339
2018
Q4 		$213K Sell
9,350
-200
-2% -$5.44K 0.03% 334
2018
Q3 		$304K Buy
9,550
+200
+2% +$6.46K 0.04% 297
2018
Q2 		$335K Buy
9,350
+1,700
+22% +$60.2K 0.04% 282
2018
Q1 		$254K Sell
7,650
-900
-11% -$32.1K 0.03% 325
2017
Q4 		$263K Buy
+8,550
New +$215K 0.03% 353

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Rothschild Investment LLC's EDIT Position: Q2 2026 in Review

Rothschild Investment LLC increased its Editas Medicine (EDIT) stake by 55% in Q2 2026, buying an estimated $947 and bringing the position to 914 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2583.

Rothschild Investment LLC first reported a position in EDIT in Q4 2017 and has held it in 21 quarters since. The position peaked at $335K in Q2 2018. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Rothschild Investment LLC held 914 shares of Editas Medicine worth $2.96K as of Q2 2026.
  • Rothschild Investment LLC bought 324 Editas Medicine shares in Q2 2026, an estimated $947.
  • Editas Medicine made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2583 holding.
  • Rothschild Investment LLC first reported a position in Editas Medicine in Q4 2017 and has held it in 21 quarters since.
  • Rothschild Investment LLC's Editas Medicine position peaked at $335K in Q2 2018.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.